12 / 1020
Academic award: Jack Fowler University of Wisconsin Award (Abs. 380)
Company Award Lectures (Abs. 381-382)
Monday 2 May 2016
Teaching Lecture
How to bring QUANTEC into the 21st century? (Abs. 383)
Shared decision making (Abs. 384)
The study of therapy resistance in genetically engineered mouse
models for BRCA1-mutated breast cancer (Abs. 385)
SBRT/SABR for oligometastatic disease (Abs. 386)
Advanced treatment strategies for head and neck cancer (Abs. 387)
Dose to water vs. dose to tissue in advanced treatment planning:
myths, realities and concerns (Abs. 388)
Nanodosimetry: from radiation physics to radiation biology (Abs. 389)
Brachytherapy for the pelvic region: status and perspective for the
future (Abs. 390-391)
Symposium with Proffered Papers
Adaptive radiotherapy for coping with anatomical variations: hope or
hype? (Abs. 392-395)
Time is not on our side: cardiovascular toxicity after radiotherapy
(Abs. 396-400)
Symposium
Emerging biomarkers (Abs. 401-404)
SBRT for oligometastatic disease (Abs. 405-407)
Head and neck: state-of-the-art and directions for future research
(Abs. 408-410)
SBRT in lung - choices and their impact on related uncertainties
(Abs. 411-413)